Atherosclerotic Cardiovascular Diseases Active Not Recruiting Phase 3 Trials for Inclisiran (DB14901)

Also known as: Atherosclerotic Cardiovascular Disease / Atheromatosis / Atherosclerotic heart disease of native coronary artery / Atherosclerosis / Atherosclerosis (morphologic abnormality) / Arteriosclerotic vascular disease (disorder) / Arteriosclerosis / Arteriosclerosis (morphologic abnormality) / Vascular sclerosis (morphologic abnormality)

IndicationStatusPhase
DBCOND0078488 (Atherosclerotic Cardiovascular Diseases)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05030428
Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular DiseaseTreatment
NCT03705234
A Randomized Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Cardiovascular DiseasePrevention